VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 60 of Oncotarget features Figure 8, "Modeling of palbociclib resistance in KRAS-mutant NSCLC cells and effects of MAP kinase pathway inhibition," by Haines, et al.
|
|
Table of Contents
News
|
| Chkmate on resistance to kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.25802
|
| 31560-31561 |
|
| CSCs: regenerating optimism for osteosarcoma treatment |
|
https://doi.org/10.18632/oncotarget.25820
|
| 31562-31563 |
|
| The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25832
|
| 31564-31565 |
Editorial
|
| Are membranes nonapoptotic compartments for apoptotic caspases |
|
https://doi.org/10.18632/oncotarget.25796
|
| 31566-31567 |
|
| Copy number of latent viruses oncogenicity and the microcompetition model |
|
https://doi.org/10.18632/oncotarget.25804
|
| 31568-31569 |
|
| AMPK activates DAPK2 to promote autophagy |
|
https://doi.org/10.18632/oncotarget.25842
|
| 31570-31571 |
Priority Research Papers
|
| Palbociclib resistance confers dependence on an FGFRMAP kinasemTORdriven pathway in KRASmutant nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25803
|
| 31572-31589 |
Research Papers
|
| Resistance to complement activation cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy |
|
https://doi.org/10.18632/oncotarget.25657
|
| 31590-31605 |
|
| Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications |
|
https://doi.org/10.18632/oncotarget.25810
|
| 31606-31619 |
|
| A comprehensive evaluation of Hippo pathway silencing in sarcomas |
|
https://doi.org/10.18632/oncotarget.25824
|
| 31620-31636 |
|
| FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker |
|
https://doi.org/10.18632/oncotarget.25827
|
| 31637-31649 |
|
| Impact of distress screening algorithm for psychooncological needs in neurosurgical patients |
|
https://doi.org/10.18632/oncotarget.25833
|
| 31650-31663 |
|
| Inbornlike errors of metabolism are determinants of breast cancer risk clinical response and survival: a study of human biochemical individuality |
|
https://doi.org/10.18632/oncotarget.25839
|
| 31664-31681 |
|
| Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCRABL |
|
https://doi.org/10.18632/oncotarget.25849
|
| 31682-31696 |
|
| Suppression of SOCS3 enhances TRAILinduced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25851
|
| 31697-31708 |
|
| A Phase Ib openlabel dosefinding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors |
|
https://doi.org/10.18632/oncotarget.25854
|
| 31709-31718 |
|
| DNA Repair Molecular Beacon assay: a platform for realtime functional analysis of cellular DNA repair capacity |
|
https://doi.org/10.18632/oncotarget.25859
|
| 31719-31743 |
|
| Advantages of systematic trunk SPECT/CT to planar bone scan PBS in more than 300 patients with breast or prostate cancer |
|
https://doi.org/10.18632/oncotarget.25860
|
| 31744-31752 |
|
| A novel fatty acidbinding protein 5estrogenrelated receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25878
|
| 31753-31770 |
|
| Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and selfrenewal capacity of pancreatic ductal epithelial cells |
|
https://doi.org/10.18632/oncotarget.25884
|
| 31771-31786 |
Corrections
|
| Correction: Halofuginone inhibits radiotherapyinduced epithelialmesenchymal transition in lung cancer |
|
https://doi.org/10.18632/oncotarget.25958
|
| 31787-31787 |
|
| Correction: Colon cancerinduced interleukin35 inhibits betacatenin mediated prooncogenic activity |
|
https://doi.org/10.18632/oncotarget.25959
|
| 31788-31788 |
|
| Correction: Characterization of HBV integration patterns and timing in liver cancer and HBVinfected livers |
|
https://doi.org/10.18632/oncotarget.25960
|
| 31789-31789 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
